Intra-Cellular Therapies Inc

Common Name
Intra-Cellular Therapies
Country
United States
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Employees
860
Ticker
ITCI
Exchange
NASDAQ/NGS
Description
Intra-Cellular Therapies Inc. is a biopharmaceutical company that innovates in the development of novel drugs for treating complex psychiatric and neurological disorders. Its primary focus is on treat...

Intra-Cellular Therapies's GHG Emissions Data Preview

In 2023, Intra-Cellular Therapies completed a corporate carbon footprint assessment and publicly disclosed its greenhouse gas (GHG) emissions according to the GHG Protocol, covering Scope 1 (direct emissions from owned or controlled sources).

However, Intra-Cellular Therapies has not published a category-level breakdown of its Scope 3 emissions, limiting visibility into specific value chain sources.

Metric (tCO2e)2023202220212020 - 2017
Total Scope 1
Copy restricted. Please purchase to unlock this data.
a
Copy restricted. Please purchase to unlock this data.
Copy restricted. Please purchase to unlock this data.
0000000
Total Scope 2
Market-Based
Copy restricted. Please purchase to unlock this data.
Copy restricted. Please purchase to unlock this data.
Copy restricted. Please purchase to unlock this data.
0000000
Location-Based
Copy restricted. Please purchase to unlock this data.
Copy restricted. Please purchase to unlock this data.
Copy restricted. Please purchase to unlock this data.
0000000
Total Scope 3
Copy restricted. Please purchase to unlock this data.
Copy restricted. Please purchase to unlock this data.
Copy restricted. Please purchase to unlock this data.
0000000
Download Intra-Cellular Therapies's GHG Emissions data for free

Create your Tracenable account today and download up to 5 company datasets of your choice for free. No credit card required.

Verified Sources Behind Intra-Cellular Therapies’s Greenhouse Gas (GHG) Emissions Data

Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform. Explore Intra-Cellular Therapies’s data sources below and access millions more through our Disclosure Search.

a. Intra-Cellular Therapies's Sustainability Report 2023
Trace every data point back to Intra-Cellular Therapies’s disclosures

Sign up for Tracenable and access millions of corporate disclosures, including annual reports and sustainability filings from global companies, completely free of charge.

Insights into Intra-Cellular Therapies's Operational Emissions

In 2023, the total operational greenhouse gas (GHG) emissions of Intra-Cellular Therapies amounted to 3,907 metric tons of CO2 equivalent. This figure reflects direct emissions from owned or controlled sources (Scope 1). a

Intra-Cellular Therapies's Scope 1 Emissions Over Time

202301 k2 k3 k4 ktCO2e
  • Total Scope 1
  • Year-over-Year Change

What are Intra-Cellular Therapies's Scope 1 emissions?

In 2023, the total Scope 1 emissions of Intra-Cellular Therapies were 3,907 metric tons of CO₂ equivalent (tCO₂e). a

Want Full Access to Intra-Cellular Therapies's GHG Emissions Dataset?
Sign Up